No Data
No Data
Form 144(Amend) | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 36.49 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $GeneDx Holdings(WGS.US)$、$GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 1.37 million shares of its co
Form 144 | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 6.96 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $GeneDx Holdings(WGS.US)$、$GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 261.42K shares of its common
GeneDx Holdings Is Maintained at Buy by BTIG
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $35
GeneDx Hldgs Analyst Ratings
Express News | GeneDx Holdings Corp : Btig Raises Target Price to $35 From $19
Mars MoooOP :![](https://emoticon.futunn.com/rich_daily_life/O_33.png)